SCTbio is a Czech CDMO specializing in cell and gene therapy (ATMP) manufacturing, spun out from SOTIO. The company provides cGMP production of cell-based therapies and retroviral/lentiviral vectors from its 2,000 sqm facility in Prague, Czech Republic. SCTbio has specialized expertise in dendritic cell therapeutics, CAR-T, and viral vector production, supported by a global network of 150 apheresis collection centers.
cell therapy manufacturing (dendritic cells, CAR-T), lentiviral and gammaretroviral vector production, ATMP development, apheresis logistics
1 site worldwide
No reviews available yet.
No documents available.